284 related articles for article (PubMed ID: 4656191)
1. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Guillard A
Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
[No Abstract] [Full Text] [Related]
2. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
3. [Indications and results of monoamine treatment in parkinsonian syndromes].
Boudin G; Pépin B; Guillard A; Fabiani JM; Haguenau M
Rev Neurol (Paris); 1972 Jul; 127(1):79-97. PubMed ID: 4520464
[No Abstract] [Full Text] [Related]
4. [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Schneider E; Fischer PA; Jacobi P; Maxion H
Arch Psychiatr Nervenkr (1970); 1973 Mar; 217(1):95-112. PubMed ID: 4695662
[No Abstract] [Full Text] [Related]
5. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
6. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Görlich J; Markus E
Dtsch Med Wochenschr; 1972 Aug; 97(34):1246-8. PubMed ID: 5048316
[No Abstract] [Full Text] [Related]
7. [Cardiovascular effects of L-dopa and decarboxylase inhibitor on patients with Parkinson's disease].
Desjacques P; Moret P; Gauthier G
Schweiz Med Wochenschr; 1973 Dec; 103(50):1783-5. PubMed ID: 4129257
[No Abstract] [Full Text] [Related]
8. Treatment of parkinsonism with levo-dopa: results in 302 cases.
Newkirk TA; Magee KR
Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
[No Abstract] [Full Text] [Related]
9. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Stammler A; Vielhaber K
Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521
[No Abstract] [Full Text] [Related]
10. [Collateral effects of L-dopa treatment in patients with parkinsonism].
Signorelli CD; D'Andrea F; De Divitiis E
Sist Nerv; 1970; 22(2):109-14. PubMed ID: 5504548
[No Abstract] [Full Text] [Related]
11. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
Jenkins AC; Schwieger AC
Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186
[No Abstract] [Full Text] [Related]
12. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
[No Abstract] [Full Text] [Related]
13. [Treatment of Parkinson's syndrome with L-dopa].
Kaeser HE; Ferel D; Wurmser P
Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
[No Abstract] [Full Text] [Related]
14. [Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].
Kaufmann W; Butz P; Wiesendanger M
Dtsch Z Nervenheilkd; 1970; 197(1):85-100. PubMed ID: 5522871
[No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
Lombardo L; de la Garza R; Ivan-Reynoso G
Arch Invest Med (Mex); 1974; 5(2):105-16. PubMed ID: 4433198
[No Abstract] [Full Text] [Related]
16. [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].
Birkmayer W
Wien Klin Wochenschr; 1969 Sep; 81(39):677-9. PubMed ID: 5344299
[No Abstract] [Full Text] [Related]
17. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Siegfried J; Klaiber R; Perret E; Ziegler WH
Dtsch Med Wochenschr; 1969 Dec; 94(52):2678-81. PubMed ID: 4903342
[No Abstract] [Full Text] [Related]
19. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
Wajsbort J; Hemli JA; Alfandary I; Yahel M; Siegfried J
Wien Med Wochenschr; 1971 Oct; 121(42):741-5. PubMed ID: 5115985
[No Abstract] [Full Text] [Related]
20. [Current treatment of the Parkinsonian syndrome].
Voiculescu V
Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
